Heat therapy reduces sympathetic activity and improves cardiovascular risk profile in women who are obese with polycystic ovary syndrome.

ABSTRACT

Polycystic ovary syndrome (PCOS) affects up to 15% of women and is associated with increased risk of obesity and cardiovascular disease. Repeated passive heat exposure [termed "heat therapy" (HT)] is a lifestyle intervention with the potential to reduce cardiovascular risk in obesity and PCOS. Women with obesity (n = 18) with PCOS [age 27 ± 4 yr, body mass index (BMI) 41.3 ± 4.7 kg/m2] were matched for age and BMI, then assigned to HT (n = 9) or time control (CON; n = 9). HT subjects underwent 30 one-hour hot tub sessions over 8-10 wk, whereas CON subjects did not undergo HT. Muscle sympathetic nerve activity (MSNA), blood pressure, cholesterol, C-reactive protein, and markers of vascular function were assessed at the start (Pre) and end (Post) of 8-10 wk. These measures included carotid and femoral artery wall thickness and flow-mediated dilation (FMD), measured both before and after 20 min of ischemia-20 min of reperfusion (I/R) stress. HT subjects exhibited reduced MSNA burst frequency (Pre 20 ± 8 bursts/min, Post 13 ± 5 bursts/min, P = 0.012), systolic (Pre 124 ± 5 mmHg, Post 114 ± 6 mmHg; P < 0.001) and diastolic blood pressure (Pre 77 ± 6 mmHg, Post 68 ± 3 mmHg; P < 0.001), C-reactive protein (Pre 19.4 ± 13.7 nmol/L, Post 15.2 ± 12.3 nmol/L; P = 0.018), total cholesterol (Pre 5.4 ± 1.1 mmol/L, Post 5.0 ± 0.8 mmol/L; P = 0.028), carotid wall thickness (Pre 0.054 ± 0.005 cm, Post 0.044 ± 0.005 cm; P = 0.010), and femoral wall thickness (Pre 0.056 ± 0.009 cm, Post 0.042 ± 0.005 cm; P = 0.003). FMD significantly improved in HT subjects over time following I/R (Pre 5.6 ± 2.5%, Post 9.5 ± 1.7%; P < 0.001). No parameters changed over time in CON, and BMI did not change in either group. These findings indicate that HT reduces sympathetic nerve activity, provides protection from I/R stress, and substantially improves cardiovascular risk profiles in women who are obese with PCOS.